Expression, function, and clinical implications of the estrogen receptor β in human lung cancers

Biochemical and Biophysical Research Communications

Volumn 285, Issue 2, 2001, Pages 340-347

  Omoto, Yoko ^a,b   Tsuchiya, Eiju ^a   Eguchi, Hidetaka ^a   Hayashi, Shin ichi ^a   Kobayashi, Yasuhito ^a   Yamori, Takao ^b   Iwase, Hirotaka ^b   Nakagawa, Ken ^c   Ishikawa, Yuichi ^d   Warner, Margaret ^e,f   Gustafsson, Jan Åke ^e,f  

^a SAITAMA CANCER CENTER   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c Cancer Institute Hospital   (Japan)

^d CANCER INSTITUTE   (Japan)

^e Department of Medical Nutrition ^*  (Sweden)

^f KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adenocarcinoma; Estrogen receptor ; Lung cancer

Indexed keywords

ANTIESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ESTROGEN RESPONSIVE ELEMENT; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG SQUAMOUS CELL CARCINOMA; MALE; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034811996     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.5158     Document Type: Article

References (42)

1. Estimates of the world wide incidence of eighteen major cancers in 1985
2. Comparison of lung cancer incidence rates by histological type in high and low incidence countries, with reference to the limited role of smoking
3. Risk of lung cancer among cigarette smokers in relation to tumor location
4. Young lung cancer patients in Japan: Different characteristics in the sexes
5. Association between smoking and tumor progression in Japanese women with adenocarcinoma of the lung
6. Long-term survivors in metastatic nonsmall-cell lung cancer: An Eastern Cooperative Oncology Group study
7. Survival determinants in extensive-stage nonsmall-cell lung cancer: The Southwest Oncology Group experience
8. Somatic mutations of the MTS (multiple tumor suppressor) 1/CDK41 (cyclin-dependent kinase-4 inhibitor) gene in human primary nonsmall cell lung carcinomas
9. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung
10. High K-ras mutation rates in goblet-cell-type adenocarcinomas of the lungs
11. A follow-up study of progression from dysplasia to squamous cell carcinoma with immunohistochemical examination of p53 protein overexpression in the bronchi of ex-chromate workers
12. Identification of a 910-kb region of common allelic loss in chromosome bands 16q24.1-q24.2 in human lung cancer
13. Chromosome bands 3p14.2, 9p21, and 13q14 are frequently deleted in roentgenographically occult bronchogenic squamous cell carcinoma of the lung
14. The expression of p73 is increased in lung cancer, independent of p53 gene alteration
15. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage nonsmall cell lung carcinomas
16. Three new regions on chromosome 17p13.3 distal to p53 with possible tumor suppressor gene involvement in lung cancer
17. Different subtypes of human lung adenocarcinoma caused by different etiologic factors: Evidence from p53 mutational spectra
18. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer
19. Natural history of inoperable hepatocellular carcinoma: Estrogen receptors’ status in the tumor is the strongest prognostic factor for survival
20. Expression of oestrogen and progesterone receptors in gastric cancer: A flow cytometric study
21. Estrogen and progesterone receptors in gastric and colorectal cancer
22. Expression of estrogen and progesterone receptors in nonsmall-cell lung cancer: Immunohistochemical study
23. Estrogen receptor detection in paraffin sections of adenocarcinoma of the colon, pancreas, and lung
24. Estrogen and progesterone receptors in bronchogenic carcinoma
25. Steroid receptors in human lung cancer
26. Sex hormone receptors in nonsmall-cell lung cancer in human beings
27. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
28. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptor α and β
29. Estrogen receptor α and β in the rodent mammary gland
30. Different expression patterns of Bcl-2 family genes in breast cancer by estrogen receptor status with special reference to pro-apoptotic Bak gene
31. Unique response pathways are established by allosteric interactions among nuclear hormone receptors
32. The complete primary structure of human estrogen receptor β (hERβ) and its heterodimerization with ERα in vivo and in vitro
33. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
34. Regulation of estrogen receptor α gene mediated by promoter B responsible for its enhanced expression in human breast cancer
35. Molecular cloning of the human Ah receptor gene promoter
36. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β
37. Immunolocalisation of oestrogen receptor beta in human tissues
38. Estrogen and progesterone receptors in nonsmall cell lung cancer in 248 consecutive patients who underwent surgical resection
39. The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens
40. Estrogen receptor (ER) β, a modulator of ERα in the uterus
41. Estrogen receptor beta knock out leads to hyperplasia in the ventral prostate
42. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites